4
Changes in Ownership
Cytek Biosciences, Inc. Filed Acc 0001209191-23-016977
Options or other derivatives
- Chief Commercial Officer acquired 110,953 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Garland Jonathan Todd Chief Commercial Officer | 2023-03-03 | Grant or award · Employee Stock Option (right to buy) | +66,773 | 66,773 | D | ||
| Garland Jonathan Todd Chief Commercial Officer | 2023-03-03 | Grant or award · Restricted Stock Units | +44,180 | 44,180 | D | ||
Loading xslF345X03/doc4.xml…